American Head and Neck International Conference
American Head and Neck International Conference
批准号:
10753698
负责人:
EBEN L. ROSENTHAL
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-07-01 至 2024-06-30
关键词:
AllyAmericanAreaAwardBasic ScienceCanadaCaringChildChild CareClinicalCollaborationsDay CareDedicationsDentalDentistryDisciplineEducationEnsureFamiliarityFamilyFosteringFundingGrantGuidelinesHead and Neck CancerHead and Neck SurgeryHead and neck structureHealthImprove AccessInstructionInternationalKnowledgeMeasuresMedical OncologyMental HealthNurse&aposs RoleNutritionistOncologistOncologyOutcomePainPaperParentsParticipantPathogenesisPathologyPatientsPostdoctoral FellowQuality of lifeRadiation OncologyRadiology SpecialtyRadiology, Head, NeckRehabilitation therapyReportingRequest for ApplicationsResearchResearch PersonnelScheduleScienceScientistSocial WorkersSocietiesSpecialistSpeech PathologistSpeech PathologyStudentsSurveysTranslationsTravelUnderrepresented MinorityUnderrepresented Populationscancer carecare systemscostdesignfollow-upfunctional outcomeshead and neck cancer patientlecturesmedical specialtiesmeetingsmultidisciplinarynew technologynext generationphysical therapistpostersprogramssurvivorshipsymposiumtranslational scientisttreatment program
中文摘要
项目摘要/摘要
第十一届头颈部癌症国际会议将于2023年7月8日至12日在加拿大蒙特利尔举行,
旨在促进实践者、受训者和研究人员之间的讨论,重点是如何
协作、多学科的治疗和康复可以带来最好的肿瘤学、功能性和
头颈癌患者的生活质量结果。美国头颈协会赞助商
这次会议每三年举行一次,吸引了1500多名代表各学科的与会者
医学肿瘤学、放射肿瘤学、放射学和头颈外科,以确保教育
专业内部和专业之间的互动可加强多学科协作关系。
会议的目标包括:i)加深对海德的了解,找出我们对海德的理解中的差距
和宫颈癌护理,并促进在多个学科内部和之间的这些领域的研究
代表;二)认识到护士、言语病理学家、听觉学家、营养学家、社会学家
工作人员、疼痛专家、心理健康从业者、物理治疗师和牙科肿瘤学家
最大的功能结果,并在适当的功能评估和报告新的功能结果
治疗方案;以及iii)提供对正在帮助我们的新兴研究突破的熟悉
更好地了解头颈部癌的发病机制和治疗。在此申请资金
申请,以便通过以下途径改善学员和年轻家庭参加会议的机会
(1)学生、住院医生、临床研究员和博士后研究员的见习旅行奖励,特别是
重点支持代表人数不足的少数族裔与会者,以及(2)在会议上提供托儿服务,以
降低上班族父母的入学门槛。这一支持将通过以下方式加强会议参与度
不同的实习生、临床医生和研究人员小组,使他们有机会展示他们的研究成果,
开展协作,并与该领域的专家互动。
英文摘要
Project Summary/Abstract
The 11th International Conference on Head and Neck Cancer to be held July 8-12, 2023, in Montreal, Canada,
is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how
collaborative, multidisciplinary treatment and rehabilitation can lead to the best oncologic, functional, and
quality of life outcomes for head and neck cancer patients. The American Head and Neck Society sponsors
this meeting, which occurs every three years and attracts well over 1500 attendees representing the disciplines
of medical oncology, radiation oncology, radiology, and head and neck surgery, to ensure educational
interactions within and between specialties that can strengthen multidisciplinary collaborative relationships.
Objectives for the meeting include i) to further understanding and to identify gaps in our understanding of head
and neck cancer care, and foster research in those areas within and between the multiple disciplines
represented; ii) to recognize the important role of nurses, speech pathologists, audiologists, nutritionists, social
workers, pain specialists, mental health practitioners, physical therapists, and dental oncologists in achieving
maximal functional outcomes, and in proper functional assessment and reporting of functional results of new
treatment programs; and iii) to provide familiarity with emerging research breakthroughs that are helping us to
better understand the pathogenesis and treatment of head and neck cancer. Funds are requested in this
application in order to improve access to the conference for trainees and young families through
(1) Trainee travel awards for students, residents, clinical fellows, and postdoctoral fellows, with a particular
focus on supporting underrepresented minority attendees, and (2) Providing childcare at the meeting to
reduce barriers to attendance for working parents. This support will enhance conference participation by
diverse groups of trainees, clinicians, and researchers, giving them the opportunity to present their research,
develop collaborations, and interact with experts in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
-
批准号:10671612
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2022
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
-
批准号:10508399
-
项目类别:
-
资助金额:$42.6万
-
财政年份:2022
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Next Generation Sentinel Node Mapping
-
批准号:10532064
-
项目类别:
-
资助金额:$4.91万
-
财政年份:2019
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:9586709
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:10496780
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:9727786
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
-
批准号:10164616
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2018
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:8969649
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:9342705
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Prototype optical device for image guided surgery with panitumumab-IRDye800
-
批准号:9759821
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2015
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Imaging Guided Surgery using Fluorescently Labeled Cetuximab
-
批准号:8765574
-
项目类别:
-
资助金额:$26.81万
-
财政年份:2014
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Optical imaging of primary and regional melanoma to guide surgical resection
-
批准号:8699170
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2013
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Optical imaging of primary and regional melanoma to guide surgical resection
-
批准号:8564734
-
项目类别:
-
资助金额:$19.17万
-
财政年份:2013
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
8th Annual Conference on Head and Neck Cancer
-
批准号:8319118
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2012
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8444266
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8621981
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8024535
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:8225379
-
项目类别:
-
资助金额:$26.54万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
CD147 as a Novel Target in Head and Neck Cancer
-
批准号:7899557
-
项目类别:
-
资助金额:$27.36万
-
财政年份:2010
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
Fluorescently Labeled Anti-EGFR to Guide Removal of Lymph Node Metastasis
-
批准号:7738795
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2009
-
负责人:EBEN L. ROSENTHAL
-
依托单位:
海外基金